<?xml version="1.0"?>
<Articles JournalTitle="Archives of Anesthesiology and Critical Care">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Archives of Anesthesiology and Critical Care</JournalTitle>
      <Issn>2423-5849</Issn>
      <Volume>2</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Procalcitonin, a Reliable Biomarker in Management of Sepsis</title>
    <FirstPage>165</FirstPage>
    <LastPage>168</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Shahram</FirstName>
        <LastName>Amini</LastName>
        <affiliation locale="en_US">Department of Anesthesiology and Critical Care, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Sedaghat</LastName>
        <affiliation locale="en_US">Department of Anesthesiology and Critical Care, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>11</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>11</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Procalcitonin is widely used as a biomarker for diagnosis and prognosis for sepsis and infection as well as monitoring the response to antibiotic therapy. In this study we systematically reviewed the value of procalcitonin in diagnosis, treatment, and prognosis in patients with sepsis or infection.</abstract>
    <web_url>https://aacc.tums.ac.ir/index.php/aacc/article/view/54</web_url>
    <pdf_url>https://aacc.tums.ac.ir/index.php/aacc/article/download/54/159</pdf_url>
  </Article>
</Articles>
